1 year return (CAGR)
-
Crescent Biopharma, Inc. Exchange (NASDAQ, USD)
CBIO
16.89
+0.12 (+0.72%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
627.36M
Price/Sales
14.78
Ent value
475.27M
Price/Book
3.84
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
5.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.67 |
| Daily high | 17.87 |
| Daily low | 16.15 |
| Daily Volume | 3.12M |
| All-time high | 26.98 |
| 1y analyst estimate | 30.60 |
| Beta | - |
| EPS (TTM) | -5.41 |
| Dividend per share | 0.00 |
| Ex-div date | 13 Jan 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CBIO | S&P500 | |
| Current price drop from All-time high | -37.40% | -2.08% |
| Highest price drop | -46.37% | -56.47% |
| Date of highest drop | 31 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -22.18% | -10.68% |
| Avg time to new high | 13 days | 12 days |
| Max time to new high | 104 days | 1805 days |
News
